Navigation Links
Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
Date:8/10/2012

PRINCETON, N.J., Aug. 10, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today its financial results for the second quarter ending June 30, 2012.

Soligenix's revenues for the quarter ending June 30, 2012 were $762,851 as compared to $405,820 for the second quarter of 2011. The increase in revenues was related to increased reimbursable costs from the Company's ThermoVax™, Thermostability Technology Grant focused on a novel method of rendering aluminum salt adjuvanted vaccines stable at elevated temperatures. 

Soligenix's net loss for the quarter ending June 30, 2012 was $979,878 or $(0.09) per share, as compared to $1,931,317 or $(0.18) per share for the quarter ending June 30, 2011, representing a decreased loss of $951,143. This decrease is attributable to increased gross profit related to the ThermoVax™ grant and reduced spending resulting from termination of the Phase 3 clinical trial of orBec® in acute GI GVHD. 

Research and development expenses for the quarter ending June 30, 2012 were $500,980 as compared to $1,513,722 for the quarter ending June 30, 2011. This decrease of $1,012,742 is primarily attributable to reduced spending in connection with the Phase 3 clinical trial of orBec®. General and administrative expenses for the quarter ending June 30, 2012 were $627,218, compared to $475,377 for the quarter ending June 30, 2011. This increase of $151,841 is primarily attributable to a greater share of allocated salaries to general and administrative due to decreased research and development programs.

As of June 30, 2012, the Company's cash position was approximately $4,430,000 with working capital of approximately $3,630,000.   

Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix stated, "In the second quarter of 2012 we continued progre
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
2. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
10. Luminex Corporation Reports First Quarter 2012 Results
11. Hospira Reports First-Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... and MENLO PARK, Calif. ... DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and ... commercializing proven cancer therapies in new orphan drug ... of Allowance from the U.S. Patent and Trademark ... " Compositions and methods to improve the therapeutic ...
(Date:3/2/2015)... , March 2, 2015 Attorney ... investigating potential claims on behalf of purchasers of ... or the "Company") (NasdaqGM: VTAE -News).  Such investors ... or his investor relations coordinator Eitan Kimelman ... The investigation concerns whether Vitae Pharmaceuticals and ...
(Date:3/2/2015)... Calif. , March 2, 2015 Valencia ... 48 th patient with its radically small device ... 10, 2015. Valencia,s early results in this randomized, double-blinded, controlled ... high degree of confidence that it will succeed in ... With its early clinical results, Valencia ...
Breaking Medicine Technology:DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 2DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 3DelMar Pharmaceuticals Receives Notice of Allowance of Fourth U.S. Patent Covering Methods of Use and Compositions for VAL-083 4SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2Valencia Technologies Implants its 48th Patient, Continues Equity Crowdfunding 2
... ... ... ... , ...
... , ... ... ... ...
Cached Medicine Technology:MIT Changes Its Name to Micro Identification Technologies 2MIT Changes Its Name to Micro Identification Technologies 3MIT Changes Its Name to Micro Identification Technologies 4Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 2Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 3Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 4Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 5Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 6Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 7Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 8Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 9Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 10Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 11Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 12Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 13Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 14Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 15Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 16Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 17Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 18Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 19Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 20Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 21Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 22Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 23Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 24Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 25Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 26Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 27Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 28Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 29Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 30Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 31Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 32Excellent Results in a Transformational Year for Shire; Core Product Sales up 25% 33
(Date:3/2/2015)... March 02, 2015 GBCHealth, a ... catalyzing private sector activities and investments in global ... elected four new members to serve on the ... Paul Farmer, Chief Strategist and Co-founder of Partners ... University; Dr. Huma Abbasi, General Manager of Global ...
(Date:3/2/2015)... March 02, 2015 Market Publishers Ltd ... worked out by Global Industry Analysts Inc and recently ... Market Research Report . Through 2018, the global radiation ... CAGR. The detailed research report suggests a holistic analysis ... therapy equipment as well as covers the top market ...
(Date:3/2/2015)... Just months after the U.S. ... use of power morcellators ( http://www.morcellatorlawsuit2015.com ) in ... UnitedHealthCare is poised to restrict coverage for hysterectomies ... a notification sent to physicians in January, the ... require pre-authorization for laparoscopic or abdominal hysterectomies, the ...
(Date:3/2/2015)... March 02, 2015 While many hospitals ... VI of the Civil Rights Act, the unique needs ... loss are bringing light to the value of video ... that nearly 1 in 20 U.S. children have LEP—a ... in some major cities.(1) Stratus Video Interpreting ...
(Date:3/2/2015)... 2015 Doctors in Novara, Italy have ... predictor of outcomes for people with mesothelioma than other ... of the new study on the Surviving Mesothelioma website. ... of Eastern Piedmont followed the cases of 172 ... excess lung fluid. , “Persistent lung expansion after ...
Breaking Medicine News(10 mins):Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2
... recent Florida State University study, hospitals can combat spiralling ... all hospital operations. ,According to Ken Lubben, ... and Lakewood Ranch Medical Centre, have already made big ... He said that, the hospitals are yet to reap ...
... official of China the tide has ebbed and has declared ... in the province.// ,But as a damper this claim ... senior health official was Luo Huiming, director of the Guangdong ... Institute. ,He said, "The weather has begun to get ...
... the Emirates are concerned with the proposal of the Ministry ... in the country.// ,"A committee has been set ... ministry provides for the private medical sector. This includes the ... staff, and the licensing of the medical or health establishments ...
... with avian influenza infection was Saturday admitted to ... a 30-year-old resident of Jamalpur neighborhood of the ... ,Gujarat's Health Minister Ashok Bhatt, however, denied ... negative results., ,According to Bhatt, the blood ...
... has finally broken a taboo with a study on the ... General Union of Women// supported with funds from the United ... four married women gets beaten -- usually by her husband ... awareness of the problem. ,In Syria violence against ...
... times as much sunlight as those with fair skin to ... study// . ,Researchers at the Australian National University ... summer sunshine to produce enough Vitamin D whereas dark-skinned people ... ,Acceptable levels of sunbathing also depends on geography and the ...
Cached Medicine News:Health News:Technology Can Help Fight Health Care Costs 2Health News:Technology Can Help Fight Health Care Costs 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: